Chemotherapy of human intestinal parasitic diseases.
D000562:Amebiasis / Q000188:drug therapy; D000577:Amides / Q000627:therapeutic use; D000724:Ancylostomiasis / Q000188:drug therapy; D001196:Ascariasis / Q000188:drug therapy; D001598:Bephenium Compounds / Q000627:therapeutic use; D002590:Cestode Infections / Q000188:drug therapy; D004640:Emetine / Q000627:therapeutic use; D005664:Furazolidone / Q000627:therapeutic use; D005873:Giardiasis / Q000188:drug therapy; D006801:Humans; D006912:Hydroxyquinolines / Q000627:therapeutic use; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy*; D008463:Mebendazole / Q000627:therapeutic use; D008795:Metronidazole / Q000627:therapeutic use; D009332:Necatoriasis / Q000188:drug therapy; D009534:Niclosamide / Q000627:therapeutic use; D010123:Oxyuriasis / Q000188:drug therapy; D010303:Paromomycin / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011715:Pyrantel / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011774:Pyrvinium Compounds / Q000627:therapeutic use; D011796:Quinacrine / Q000627:therapeutic use; D013322:Strongyloidiasis / Q000188:drug therapy; D013773:Tetramisole / Q000627:therapeutic use; D013827:Thiabendazole / Q000627:therapeutic use; D013861:Thiocyanates / Q000627:therapeutic use; D014257:Trichuriasis / Q000188:drug therapy
D000577:Amides; D001598:Bephenium Compounds; D006912:Hydroxyquinolines; D010879:Piperazines; D011743:Pyrimidines; D011774:Pyrvinium Compounds; D013861:Thiocyanates; D008795:Metronidazole; D011715:Pyrantel; D005664:Furazolidone; D010303:Paromomycin; D008463:Mebendazole; D009534:Niclosamide; D013773:Tetramisole; D011796:Quinacrine; D013827:Thiabendazole; D004640:Emetine